A pioneering diagnostic device identifies more abnormal cells on the cervix than standard colposcopy, according to data published in two European clinical papers.
ZEDSCANis a portable, handheld device which uses Electrical Impedance Spectroscopy (EIS) technology to detect dysplasia and cancer of the cervix. It can measure and detect tissue changes in women identified with an abnormal smear test.
UK research published in the European Journal of Gynaecological Oncology(EJGO) shows ZedScan, an adjunct to colposcopy, increases the detection of high-grade CIN in women referred with both low-grade and highgrade abnormal cytology.
The combination of ZedScan and colposcopy improved the outcome of women who were treated at first visit with over 95% having high-grade CIN on histology.
The second paper published in the European Journal of Obstretics and Gynaecology(EJOG), examines the influence of HPV genotypes on colposcopic performance. It also reveals by using ZedScan, more high-grade CIN is detected irrespective of HPV genotype.
